Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage ...

MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...

Over the past decade, the use of artificial intelligence (AI) has radically transformed the understanding and clinical approach to diabetes. Advances such ...

There could be a test to screen for type 1 diabetes after new research by scientists found early markers.

One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the ...